Francesca Rosignolo

815 total citations
19 papers, 641 citations indexed

About

Francesca Rosignolo is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Francesca Rosignolo has authored 19 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cancer Research. Recurrent topics in Francesca Rosignolo's work include Thyroid Cancer Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (3 papers). Francesca Rosignolo is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (3 papers). Francesca Rosignolo collaborates with scholars based in Italy, United States and France. Francesca Rosignolo's co-authors include Diego Russo, Valeria Pecce, Sébastiano Filetti, Marialuisa Sponziello, Cosimo Durante, Valentina Maggisano, Marilena Celano, Giuseppe Damante, Stefania Bulotta and Antonella Verrienti and has published in prestigious journals such as PLoS ONE, PLoS Genetics and Molecular and Cellular Endocrinology.

In The Last Decade

Francesca Rosignolo

19 papers receiving 636 citations

Peers

Francesca Rosignolo
Emma T. Lundsmith United States
Francesca Rosignolo
Citations per year, relative to Francesca Rosignolo Francesca Rosignolo (= 1×) peers Emma T. Lundsmith

Countries citing papers authored by Francesca Rosignolo

Since Specialization
Citations

This map shows the geographic impact of Francesca Rosignolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Rosignolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Rosignolo more than expected).

Fields of papers citing papers by Francesca Rosignolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Rosignolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Rosignolo. The network helps show where Francesca Rosignolo may publish in the future.

Co-authorship network of co-authors of Francesca Rosignolo

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Rosignolo. A scholar is included among the top collaborators of Francesca Rosignolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Rosignolo. Francesca Rosignolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Maggisano, Valentina, Marilena Celano, Saverio Massimo Lepore, et al.. (2019). Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells. Endocrine. 63(3). 545–553. 9 indexed citations
2.
Pecce, Valeria, Marialuisa Sponziello, Giuseppe Damante, et al.. (2018). A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency. PLoS Genetics. 14(10). e1007678–e1007678. 21 indexed citations
3.
Celano, Marilena, Francesca Rosignolo, Valentina Maggisano, et al.. (2017). MicroRNAs as Biomarkers in Thyroid Carcinoma. International Journal of Genomics. 2017. 1–11. 86 indexed citations
4.
Maggisano, Valentina, Marilena Celano, Giovanni Enrico Lombardo, et al.. (2017). Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells. Molecular and Cellular Endocrinology. 448. 34–40. 34 indexed citations
5.
Rosignolo, Francesca, et al.. (2017). Effects of nutraceuticals on anaplastic thyroid cancer cells. Journal of Cancer Research and Clinical Oncology. 144(2). 285–294. 40 indexed citations
6.
Rosignolo, Francesca, Lorenzo Memeo, Fabio Monzani, et al.. (2017). MicroRNA-based molecular classification of papillary thyroid carcinoma. International Journal of Oncology. 50(5). 1767–1777. 68 indexed citations
7.
Rosignolo, Francesca, Marialuisa Sponziello, Luciano Giacomelli, et al.. (2017). Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up. Journal of the Endocrine Society. 1(1). 3–13. 65 indexed citations
8.
Celano, Marilena, Chiara Mignogna, Francesca Rosignolo, et al.. (2017). Expression of YAP1 in aggressive thyroid cancer. Endocrine. 59(1). 209–212. 13 indexed citations
9.
Mio, Catia, Federica Baldan, Marialuisa Sponziello, et al.. (2017). BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells. Oncology Reports. 39(2). 582–588. 9 indexed citations
10.
Sponziello, Marialuisa, Silvia Benvenuti, Alessandra Gentile, et al.. (2017). Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer. Human Mutation. 39(3). 371–377. 17 indexed citations
11.
Rosignolo, Francesca, Marialuisa Sponziello, Cosimo Durante, et al.. (2016). Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma. PLoS ONE. 11(6). e0156658–e0156658. 19 indexed citations
12.
Sponziello, Marialuisa, Francesca Rosignolo, Marilena Celano, et al.. (2016). Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells. Molecular and Cellular Endocrinology. 431. 123–132. 107 indexed citations
13.
Verrienti, Antonella, Giovanni Tallini, Chiara Colato, et al.. (2016). RET mutation and increased angiogenesis in medullary thyroid carcinomas. Endocrine Related Cancer. 23(8). 665–676. 17 indexed citations
14.
Sponziello, Marialuisa, Antonella Verrienti, Francesca Rosignolo, et al.. (2015). PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells. Endocrine. 50(2). 434–441. 53 indexed citations
15.
Rosignolo, Francesca, Valentina Maggisano, Marialuisa Sponziello, et al.. (2015). Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression. Journal of Endocrinological Investigation. 38(12). 1283–1289. 23 indexed citations
16.
Pecce, Valeria, Mauro Biffoni, Cira Di Gioia, et al.. (2015). Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers. Endocrine. 53(1). 145–156. 15 indexed citations
17.
Sponziello, Marialuisa, Francesca Rosignolo, Cosimo Durante, et al.. (2015). Somatic amplifications and deletions in genome of papillary thyroid carcinomas. Endocrine. 50(2). 453–464. 17 indexed citations
18.
Verrienti, Antonella, Antonella Carbone, Marianna Maranghi, et al.. (2015). A Novel Double Mutation Val648ile and Val804leu of Ret Proto-Oncogene in Multiple Endocrine Neoplasia Type 2. Endocrine Practice. 21(11). 1248–1254. 8 indexed citations
19.
Forte, Stefano, et al.. (2015). The role of microRNAs in thyroid carcinomas.. PubMed. 35(4). 2037–47. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026